Skip to main content
. 2019 Apr 27;13(2):127–134. doi: 10.22074/ijfs.2019.5604

Table 2.

Clinical characteristics of participants in expression assays


Groups Menstrual cycle phase (%) Disease stage (%) BMI (kg/m2) Age (Y)

Endometriosis Proliferative (80) IV (60) 25.82 ± 4.91 30.03 ± 8.31
n=20 Secretory (20) III (40)
Controls Proliferative (80) - 24.35 ± 4.32 29.21 ± 8.72
n=20 Secretory (20)
P value NS - NS NS

Data are expressed as mean ± SEM and values in parentheses are percentages. BMI; Body mass index and NS; Not significant.